Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plitidepsin + Cytarabine in Relapsed/Refractory Leukemia
NCT00780143Phase 2Terminated
- Sponsor
- PharmaMar
- Start
- Nov 2007
- Primary completion
- Jun 2009
- Modality
- Cyclic Peptides, Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of plitidepsin in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), sponsored by PharmaMar. Started Nov 2007; status: terminated.
02
Drugs
plitidepsin
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00780143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00780143.